During the past year, laboratories across the globe have joined together to take up the fight against COVID-19 by rapidly launching clinical diagnostic assays to detect affected individuals and ultimately help curb the spread of the disease. Please join us in welcoming Dr. Ravindra Kolhe from Augusta University as he discusses his laboratory’s journey in launching a COVID-19 assay to support testing needs for the state of Georgia as well as the evolution of this assay in new workflows like pooling and varying sample types.
Take advantage of this opportunity to learn more about:
- Developing and launching a clinical diagnostic assay during a pandemic, including a discussion of the FDA EUA and LDT processes
- Adjusting to evolving needs and implementing adaptable workflows
- Continued research and work on Cycle Threshold (CT)
- Exploring future testing needs and a combined flu season
FEATURING an introduction by Madhuri Hegde, Ph.D., FACMG, SVP and CSO, PerkinElmer Global Laboratory Services